Related Experiment Videos
Infection control for gene therapy: a busy physician's primer
Martin E Evans1, Judith A Lesnaw
1Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, USA. meevan1@uky.edu
Summary
Gene therapy uses engineered viral vectors to treat genetic disorders. This review covers vector biotechnology and safety, offering infection control recommendations for clinical settings.
Area of Science:
- Biotechnology
- Infectious Diseases
- Genetics
Background:
- Gene therapy is an emerging treatment for inherited and acquired disorders.
- Various viral vectors, including retroviruses, adenoviruses, and adeno-associated viruses, are engineered for gene delivery.
- Clinical application of gene therapy necessitates evaluation of its safety and infection control implications.
Purpose of the Study:
- To review the biotechnology of gene therapy vectors.
- To summarize the safety considerations of gene therapy agents.
- To provide recommendations for infection control professionals regarding gene therapy.
Main Methods:
- Literature review of gene therapy vectors and associated safety data.
- Analysis of viral vector engineering and administration in clinical settings.
- Synthesis of current knowledge on infection control for gene therapy.
Main Results:
- Multiple viral vector types are utilized in gene therapy, each with unique characteristics.
- The safety profile of gene therapy vectors requires careful consideration in healthcare environments.
- Effective infection control strategies are crucial for the safe implementation of gene therapy.
Conclusions:
- Gene therapy holds significant promise for treating various diseases.
- Understanding vector biology and implementing robust infection control are essential for safe clinical practice.
- Infection control professionals play a vital role in ensuring patient and healthcare worker safety during gene therapy administration.